Lifescience Global

Editor’s Choice : Inhibitory Effect of a Combined Treatment of Glycyrrhizin and Caffeine on Tumor Promotion by 12-O-Tetradecanoylphorbol-13-Acetate in Two-Stage Carcinogenesis in Mouse Skin

v2n2-jpans 1351844258

Inhibitory Effect of a Combined Treatment of Glycyrrhizin and Caffeine on Tumor Promotion by 12-O-Tetradecanoylphorbol-13-Acetate in Two-Stage Carcinogenesis in Mouse Skin
Pages 202-205
Ken Yasukawa
DOI:
http://dx.doi.org/10.6000/1927-5951.2013.03.03.4
Published: 31 July 2013


Abstract: Cancer prevention is an important problem in the field of public health. Glycyrrhizin, a natural sweetening agent, is one of the components of licorice and caffeine in coffee and tea. Glycyrrhizin and caffeine were found to inhibit tumor promotion by 12-O-tetradecanoylphorbol-13-acetate (TPA) in two-stage carcinogenesis in mouse skin. Furthermore, the combined treatment of glycyrrhizin and caffeine is more effective than their single treatment on tumor promotion by TPA in mice following initiation with 7,12-dimethylbenz[a]anthracene.

Keywords: Glycyrrhizin, caffeine, combination therapy, antitumor promotion, two-stage carcinogenesis.
Download Full Article
Submit to FacebookSubmit to Google PlusSubmit to TwitterSubmit to LinkedIn

OUR STRENGTHS

♦  Worldwide readership
♦  High quality content
♦  Maximum visibility
♦  Efficient publishing
♦  Optional Open Access

Publish your Research

Survey

As an author what type of publishing model you prefer?

780
Open Access
493
Optional Open Access
338
Subscription based
5 Votes left